Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
July 1, 2025 Off

Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure

By GlobeNewswire

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) — Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases,…

July 1, 2025 Off

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities

By GlobeNewswire

SEATTLE and VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty…

July 1, 2025 Off

COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders

By GlobeNewswire

TORONTO, ONTARIO, June 30, 2025 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) (“COSCIENS” or the “Company”), a…

July 1, 2025 Off

Avicanna Announces Results of Annual General Meeting

By GlobeNewswire

TORONTO, June 30, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a…

July 1, 2025 Off

Aptose Announces Deferral of Interest Payment

By GlobeNewswire

SAN DIEGO and TORONTO, June 30, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC:…

June 28, 2025 Off

Flower Expo Returns to Michigan and Illinois This Summer Following Blockbuster Northeast Event

By GlobeNewswire

Two-day cannabis trade events will connect brands, dispensaries, and budtenders for networking, product showcases, and business growth. Attendees engage in…

June 28, 2025 Off

Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock

By GlobeNewswire

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today that,…

June 28, 2025 Off

Pliant Therapeutics Provides Update on BEACON-IPF

By GlobeNewswire

Bexotegrast development in IPF discontinued Clinical oncology program and early-stage programs continue Recent workforce and operational changes align with next…

June 28, 2025 Off

RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening

By GlobeNewswire

Cost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans, PET Scans, and EchocardiogramsAPOLLO BEACH,…

June 28, 2025 Off

INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

By GlobeNewswire

Boca Raton, Florida, June 27, 2025 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and…

Posts pagination

Previous 1 … 128 129 130 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine